Merck KGaA 1 may 2026 Merck KGaA Backs Hybrid Cancer Drugs And Greener Lab Consumables - simplywall.st
Merck KGaA 1 may 2026 Merck KGaA doses first patient in Phase III programme of enpatoran - Clinical Trials Arena
Merck KGaA 28 abr 2026 Remepy, Merck KGaA pair up to test app-paired drug model in rare tumour - FirstWord Pharma
Merck KGaA 28 abr 2026 Merck KGaA and Remepy join forces to develop combo drug-digital therapies - Medical Device Network
Merck KGaA 27 abr 2026 Merck KGaA: Small Breakout In 2026, Followed By Normalization (OTCMKTS:MKGAF) - Seeking Alpha
Merck KGaA 1 abr 2026 Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business - Merck Group